Abstracts

470 – Females With HIV Favor Interferon Responses Over Inflammation Upon TLR7 Activation

Background Females have lower viral setpoints and are more likely to control HIV infection without ART than males, though the mechanisms remain unclear. The X-chromosome-encoded ssRNA receptor TLR7 may contribute to this difference as evasion of X-inactivation in females can increase TLR7 expression. TLR7 activation induces type-I Interferon (IFN) release and production of pro-inflammatory cytokines, but its…

424 – Detection of Anti-Interferon Alpha/Omega Neutralizing Autoantibodies in PLWH

Background Anti-type I interferon (IFN-I) neutralizing autoantibodies (NABs) have been associated with an increased risk of life-threatening viral infections, including SARS-CoV-2, influenza virus and more recently West Nile virus. Given the detrimental role of IFN-I in HIV-1 infection, it is imperative to investigate anti-IFN NABs and associated IFN pathway modulation in people living with HIV…

499 – Genetic Regulation of Immune Responses to CMV in Spontaneous HIV Controllers

Background HIV controllers (HICs) spontaneously control an HIV infection and are important to understand HIV immunopathogenesis. We previously showed that HIV-control associated genetic variants in the MHC locus downregulate IL-1β and TNF-α responses to CMV pp65 in PBMCs in people living with HIV (PLHIV) (CROI 2024, abstract 319). Here, we investigated how cytokine responses are organized…

430 – Therapeutic HIV Vaccine ± TLR4 Adjuvant Impact on Monocyte Subsets in Early-Treated Youths With HIV

Background Monocytes (MO) play a crucial role in restricting HIV replication and spread. After HIV acquisition, MO show increased activation and differentiation, altering subset distribution despite ART. MO enhance vaccine induced immune responses and contribute to trained immunity, boosting protection. We here investigated changes in MO phenotype in a therapeutic vaccine study. Methods HVRRICANE is the 1st…

410 – Differential Restoration of HIV-Specific CD8+ T Cells by Amino Acid and Lipid Metabolism Modulation

Background Priming of CD8+T cells with dendritic cells (DC) is a promising approach to reduce viral reservoirs in people with HIV (PWH). HIV-specific CD8+T responses in PWH are affected by PD-1, TIGIT and TIM3 expression in these cells. Here, we studied transcriptional, metabolic and functional characteristics of memory CD8+T cells differentially expressing these checkpoint receptors and…

472 – Diminished Immune Imprinting at the Upper Respiratory Tract Following SARS-CoV-2 Breakthrough Infection

Background Immune imprinting, also known as original antigenic sin, refers to the effects prior exposures have on subsequent immunity against antigenically related viruses. The immune imprinting of humoral immunity at anatomic sites of the respiratory tract following SARS-CoV-2 breakthrough infection is not well understood.  Methods Ninety-six adult donors with COVID-19 vaccination and breakthrough infection (BTI)…

387 – Ultra-Low Level Soluble p24 Is Associated With Inflammation in People With HIV on Suppressive ART

Background Despite suppressive ART, residual inflammation persists in people with HIV (PWH), thus driving higher risk of SNAEs and mortality. Circulating HIV proteins have been detected in some suppressed PWH, as an expression of the persistence of translation-competent proviruses. We therefore seek to investigate whether peripheral inflammation and mortality risk are associated with production of p24 in…

364 – Secreted ORF8 Reprograms Macrophages to Enhance Lung Epithelial Cell Infection by SARS-CoV-2

Background ORF8 is an accessory protein encoded by SARS-CoV-2, containing an immunoglobulin-like domain of approximately 20 kDa, and is secreted extracellularly by infected cells. Serum levels of ORF8 have been shown to correlate with disease severity in COVID-19 patients, though its exact function and target cells remain unknown. We hypothesized that extracellular ORF8 influences COVID-19…

359 – Single-Cell Multi-Omics Uncovers the Immune Heterogeneity in HIV-Infected INRs

Background Immunological non-responders (INRs) are people living with HIV-1 who fail to achieve full immune reconstitution despite long-term effective antiretroviral therapy (ART). This incomplete recovery of CD4+ T cells increase the risk of opportunistic infections and non-AIDS-related morbidity and mortality. Understanding the mechanisms driving this immune dysfunction is critical for developing targeted therapies.  Methods We…